BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38056136)

  • 1. Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications.
    Banerjee A; Bardhan A; Sarkar P; Datta C; Pal DK; Saha A; Ghosh A
    Pathol Res Pract; 2024 Jan; 253():154970. PubMed ID: 38056136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
    Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
    BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for TET-mediated DNA demethylation as an epigenetic alteration in cumulus granulosa cells of women with polycystic ovary syndrome.
    Sagvekar P; Shinde G; Mangoli V; Desai SK; Mukherjee S
    Mol Hum Reprod; 2022 Jun; 28(7):. PubMed ID: 35640568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
    Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
    Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of TET Family Gene Expression and 5-Hydroxymethylcytosine as Potential Epigenetic Markers in Non-small Cell Lung Cancer.
    Alrehaili AA; Gharib AF; Alghamdi SA; Alhazmi A; Al-Shehri SS; Hagag HM; Alsaeedi FA; Alhuthali HM; Raafat N; Etewa RL; Elsawy WH
    In Vivo; 2023; 37(1):445-453. PubMed ID: 36593050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
    Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
    Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High nuclear expression of DNMT1 in correlation with inactivation of TET1 portray worst prognosis among the cervical carcinoma patients: clinical implications.
    Dutta P; Basu M; Roy A; Mandal RK; Panda CK
    J Mol Histol; 2023 Feb; 54(1):89-102. PubMed ID: 36692670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TET enzymes are successively expressed during human spermatogenesis and their expression level is pivotal for male fertility.
    Ni K; Dansranjavin T; Rogenhofer N; Oeztuerk N; Deuker J; Bergmann M; Schuppe HC; Wagenlehner F; Weidner W; Steger K; Schagdarsurengin U
    Hum Reprod; 2016 Jul; 31(7):1411-24. PubMed ID: 27141042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of ten-eleven translocation genes in endometrial cancers.
    Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
    Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tet2- and Tet3- Mediated Cytosine Hydroxymethylation in Six2 Progenitor Cells in Mice Is Critical for Nephron Progenitor Differentiation and Nephron Endowment.
    Liang X; Aranyi T; Zhou J; Guan Y; Hu H; Liu H; Susztak K
    J Am Soc Nephrol; 2023 Apr; 34(4):572-589. PubMed ID: 36522157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET enzymes and 5hmC epigenetic mark: new key players in carcinogenesis and progression in gynecological cancers.
    Zacapala-Gómez AE; Mendoza-Catalán MA; Antonio-Véjar V; Jiménez-Wences H; Ortíz-Ortíz J; Ávila-López PA; Baños-Hernández CJ; Salmerón-Bárcenas EG
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1123-1134. PubMed ID: 38375718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.
    Alivand MR; Soheili ZS; Pornour M; Solali S; Sabouni F
    J Cell Biochem; 2017 Oct; 118(10):3193-3204. PubMed ID: 28252217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts.
    Hattori M; Yokoyama Y; Hattori T; Motegi S; Amano H; Hatada I; Ishikawa O
    Exp Dermatol; 2015 Nov; 24(11):841-6. PubMed ID: 26013976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.
    Wang K; Chen Z; Shi J; Feng Y; Yu M; Sun Y; Zhuang Q; Liang B; Luo G; Xu X; Fan M
    Prostate; 2020 Sep; 80(12):977-985. PubMed ID: 32542727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
    Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
    Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
    Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
    Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer.
    Henrique R; Oliveira AI; Costa VL; Baptista T; Martins AT; Morais A; Oliveira J; Jerónimo C
    BMC Genomics; 2013 Dec; 14():898. PubMed ID: 24344919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.
    Cakouros D; Hemming S; Gronthos K; Liu R; Zannettino A; Shi S; Gronthos S
    Epigenetics Chromatin; 2019 Jan; 12(1):3. PubMed ID: 30606231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.